NanoDrops Vision
Vision correction with peace of mind for doctors and patients.
One technology.
Multiple indications.
Presbyopia is a physiological insufficiency of optical accommodation associated with the aging of the eye, it results in progressively worsening ability to focus clearly on close objects.
Addressing presbyopia as our first indication
The Problem
Lack of a long-lasting, spectacle-free solution for the pre-cataract presbyopia patients
The Solution
An add-on platform for presbyopia correction using existing refractive lasers
Unique Value Proposition
Confidence & peace of mind: an adjustable and reversible procedure
Unique Value Proposition
Eliminates the need for reading glasses
Access to Choice:
Temporary or
long-lasting solution
Restoring near vision while preserving
distance vision
Micro-Invasive, Extraocular:
Crystalline lens and
corneal integrity preserved
Add-on kit designed
for use with
existing lasers
Keeps future options open:
Monofocal / EDOF / multifocal IOLs
A Team That Has
Done This Before
Daria Lemann-Blumenthal, LL.B., EMBA
CEO
Former CEO and Co-Founder, BELKIN Vision
Acquired by Alcon for $466M
Arik Hybloom, CPA
CFO
Former CFO, BELKIN Vision
Director at Make a Wish
Prof. David Smadja, MD
Co-founder & CMO
Chair of the Innovation Committee of the International Society of Refractive Surgery
Keren Reuveni, M.Sc.
Clinical Affairs Director
MedTech Clinical Affairs Professional
Dana Leitman, M.Sc., EMBA
VP QA/RA
Former Head of APAC
Arcondis Group
Yifat Harel, PhD
Bio-Chemical Scientist
Research Lab Manager,
Bar Ilan University
Eran Kaplan, M.Sc.
CTO
Former VP R&D and CEO, IOPtima
Jay Stark, MBA
Commercial Strategy Lead
Former leader at Alcon (18 years)
Board of Directors
Assaf Barnea
Chairman of the Board
Managing Partner
Sanara Ventures
David Ben Ami
Director
Rick Heinick
Founder, Solo VC
Eli Yered
Partner and CFO
Sanara Ventures
Prof. David Smadja, MD
Co-founder & CMO
Prof. Zeev Zalevsky PhD
VP for Academia-Industry Relations, Bar Ilan University
NanoDrops Co-founder
